Name: National Strategy for Combating Antibiotic-Resistant Bacteria (en Inglés)
SKU: 57604935
Price: 26.89 USD
Availability: InStock
Author: Executive Office of the President

portada National Strategy for Combating Antibiotic-Resistant Bacteria (en Inglés)

National Strategy for Combating Antibiotic-Resistant Bacteria (en Inglés)

Formato

Libro Físico

Editorial

Createspace

Autor

Executive Office of the President

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

28x21.6x0.2 cm

Peso

0.11 kg.

ISBN13

9781503014398

Categorías

Guerra y defensa

National Strategy for Combating Antibiotic-Resistant Bacteria (en Inglés)

Executive Office Of The President (Autor) · Createspace · Tapa Blanda

Libro Nuevo Importado

Envío: 20 a 27 días háb.

$ 53.79$ 26.89

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 26.89

Llega entre el 22 Sep y el 05 Oct a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "National Strategy for Combating Antibiotic-Resistant Bacteria (en Inglés)"

The discovery of antibiotics in the early 20th century fundamentally transformed human and veterinary medicine. Antibiotics now save millions of lives each year in the United States and around the world. The rise of antibiotic-resistant bacterial strains, however, represents a serious threat to public health and the economy. The CDC estimates that annually at least two million illnesses and 23,000 deaths are caused by antibiotic-resistant bacteria in the United States alone.As more strains of bacteria become resistant to an ever-larger number of antibiotics, our drug choices will become increasingly limited and expensive and, in some cases, nonexistent. If this trend continues unchecked, a wide range of modern medical procedures, from basic dental care to organ transplants, likely would be accompanied by a much greater risk of developing a difficult-to-treat or untreatable antibiotic infection. The safety of many modern medical procedures is dependent on the ability to treat bacterial infections that can arise as post-treatment complications.